Pancreas Cancer News and Archives
	Targeting Vascular Endothelial Growth Factor in Advanced Carcinoid Tumor: A Random Assignment Phase II Study of Depot Octreotide with Bevacizumab and Pegylated Interferon Alpha-2b March 10, 2008 J Clin Oncol. 2008 Mar 10;26(8):1316-23. PMID: 18323556 [Abstract]
	For educational purposes only; not to be relied upon Please read Pancreatica Disclaimer
	Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us
	webmaster
	©2000-2008 Pancreatica.org - All Rights Reserved www.pancreatica.org